Literature DB >> 20080535

Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.

Jing Wang1, Yali Li, Yuki Kinjo, Thien-Thi Mac, Darren Gibson, Gavin F Painter, Mitchell Kronenberg, Dirk M Zajonc.   

Abstract

Invariant natural killer T cells (iNKT cells) respond to CD1d-presented glycolipids from Borrelia burgdorferi, the causative agent of Lyme disease. Although mouse and human iNKT cells respond to different antigens based on subtle differences in their fatty acids, the mechanism by which fatty acid structure determines antigenic potency is not well understood. Here we show that the mouse and human CD1d present glycolipids having different fatty acids, based in part upon a difference at a single amino acid position that is involved in positioning the sugar epitope. CD1d also can bind nonantigenic lipids, however, but unexpectedly, mouse CD1d orients the two aliphatic chains of a nonantigenic lipid rotated 180 degrees, causing a dramatic repositioning of the exposed sugar. Therefore, our data reveal the biochemical basis for the high degree of antigenic specificity of iNKT cells for certain fatty acids, and they suggest how microbes could alter fatty acid biosynthesis as an immune evasion mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080535      PMCID: PMC2824385          DOI: 10.1073/pnas.0909479107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.

Authors:  Stéphane Sidobre; Olga V Naidenko; Bee-Cheng Sim; Nicholas R J Gascoigne; K Christopher Garcia; Mitchell Kronenberg
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

3.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

4.  The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs.

Authors:  Carlos Cantu; Kamel Benlagha; Paul B Savage; Albert Bendelac; Luc Teyton
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 5.  Highly conserved antigen-presenting function of CD1d molecules.

Authors:  L Brossay; M Kronenberg
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 6.  Molecular interactions mediating T cell antigen recognition.

Authors:  P Anton van der Merwe; Simon J Davis
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 7.  Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.

Authors:  Dirk M Zajonc; Mitchell Kronenberg
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

8.  Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Authors:  Daniel G Pellicci; Onisha Patel; Lars Kjer-Nielsen; Siew Siew Pang; Lucy C Sullivan; Konstantinos Kyparissoudis; Andrew G Brooks; Hugh H Reid; Stephanie Gras; Isabelle S Lucet; Ruide Koh; Mark J Smyth; Thierry Mallevaey; Jennifer L Matsuda; Laurent Gapin; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

9.  Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells.

Authors:  Yuki Kinjo; Bo Pei; Simone Bufali; Ravinder Raju; Stewart K Richardson; Masakazu Imamura; Masakazu Fujio; Douglass Wu; Archana Khurana; Kazuyoshi Kawahara; Chi-Huey Wong; Amy R Howell; Peter H Seeberger; Mitchell Kronenberg
Journal:  Chem Biol       Date:  2008-07-21

10.  NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi.

Authors:  Emmanuel Tupin; Mohammed Rafii-El-Idrissi Benhnia; Yuki Kinjo; Rebeca Patsey; Christopher J Lena; Matthew C Haller; Melissa J Caimano; Masakazu Imamura; Chi-Huey Wong; Shane Crotty; Justin D Radolf; Timothy J Sellati; Mitchell Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

View more
  67 in total

1.  Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.

Authors:  Esther Dawen Yu; Enrico Girardi; Jing Wang; Thien-Thi Mac; Karl O A Yu; Serge Van Calenbergh; Steven A Porcelli; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 2.  Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation.

Authors:  J-P Jukes; N D Jones
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

3.  Divergent synthetic approach to 6''-modified α-GalCer analogues.

Authors:  Nora Pauwels; Sandrine Aspeslagh; Gerd Vanhoenacker; Koen Sandra; Esther D Yu; Dirk M Zajonc; Dirk Elewaut; Bruno Linclau; Serge Van Calenbergh
Journal:  Org Biomol Chem       Date:  2011-11-01       Impact factor: 3.876

Review 4.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

5.  Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.

Authors:  Bo Pei; Anneliese O Speak; Dawn Shepherd; Terry Butters; Vincenzo Cerundolo; Frances M Platt; Mitchell Kronenberg
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

6.  Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.

Authors:  Jerome Kerzerho; Esther D Yu; Carolina M Barra; Elisenda Alari-Pahissa; Elisenda Alari-Pahisa; Enrico Girardi; Youssef Harrak; Pilar Lauzurica; Amadeu Llebaria; Dirk M Zajonc; Omid Akbari; A Raúl Castaño
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

7.  Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Authors:  Ramesh Chandra Halder; Cynthia Tran; Priti Prasad; Jing Wang; Dhiraj Nallapothula; Tatsuya Ishikawa; Meiying Wang; Dirk M Zajonc; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2018-12-18       Impact factor: 5.532

Review 8.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

Review 9.  The CD1 size problem: lipid antigens, ligands, and scaffolds.

Authors:  Dalam Ly; D Branch Moody
Journal:  Cell Mol Life Sci       Date:  2014-08       Impact factor: 9.261

Review 10.  Coevolution of T-cell receptors with MHC and non-MHC ligands.

Authors:  Caitlin D Castro; Adrienne M Luoma; Erin J Adams
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.